Trial intelligence / Profile preview

CASA RELAX: Restrictive vs Liberal Post-operative Antibiotics for Appendicitis

NCT05966454Phase 4Terminated

Sponsor
University of California, San Francisco
Start
Jun 2023
Primary completion
Jul 2025
Countries
1
01

Overview

Phase 4, randomised trial in appendicitis (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Number of Participants With Infectious/Antibiotic Complication at 30 days and Number of Participant Deaths at 30 days. Started Jun 2023; status: terminated.

02

Conditions

appendicitis

Beyond the preview

Go deeper on NCT05966454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05966454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call